Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cingulate Inc. - Warrants
(NQ:
CINGW
)
0.0369
+0.0022 (+6.34%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Mar 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
48,510
Open
0.0327
Bid (Size)
0.0317 (3,300)
Ask (Size)
0.0369 (1,400)
Prev. Close
0.0347
Today's Range
0.0314 - 0.0369
52wk Range
0.0202 - 0.1750
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Cingulate Announces Presentation of Full Trial Results from Phase 3 Adult Efficacy and Safety Trial of CTx-1301 (dexmethylphenidate) for ADHD at Psych Congress 2023
September 05, 2023
Data Accepted as Finalist for First Annual Poster Awards
From
Cingulate Inc.
Via
GlobeNewswire
Cingulate Inc. Reports Second Quarter 2023 Financial Results and Provides Clinical and Business Update
August 14, 2023
From
Cingulate Inc.
Via
GlobeNewswire
Performance
YTD
-38.5%
-38.5%
1 Month
-56.6%
-56.6%
3 Month
-6.1%
-6.1%
6 Month
-34.2%
-34.2%
1 Year
-4.9%
-4.9%
More News
Read More
Cingulate Announces Positive Top-Line Results from Phase 3 Adult Efficacy and Safety Trial of CTx-1301 (dexmethylphenidate) for ADHD
July 11, 2023
From
Cingulate Inc.
Via
GlobeNewswire
Cingulate Successfully Manufactures Clinical Supply – Initiation of Pediatric Phase 3 Studies to Commence in July and August
June 29, 2023
From
Cingulate Inc.
Via
GlobeNewswire
Cingulate Completes Phase 3 Adult Trial of CTx-1301 (dexmethylphenidate) for ADHD
June 08, 2023
From
Cingulate Inc.
Via
GlobeNewswire
Cingulate to Present at 13th Annual LD Micro Invitational
May 25, 2023
From
Cingulate Inc.
Via
GlobeNewswire
Cingulate, Indegene to Participate in Benzinga All Live Access Event
May 12, 2023
From
Cingulate Inc.
Via
GlobeNewswire
Cingulate Inc. Reports First Quarter 2023 Financial Results and Provides Clinical and Business Update
May 10, 2023
From
Cingulate Inc.
Via
GlobeNewswire
Cingulate Announces Successful Transfer of CTx-1301 (dexmethylphenidate) Proprietary PTR™ Manufacturing Processes to Societal CDMO
May 03, 2023
From
Cingulate Inc.
Via
GlobeNewswire
Cingulate to Participate in Benzinga All Live Access Event
April 14, 2023
From
Cingulate Inc.
Via
GlobeNewswire
Cingulate Completes First Cohort of Phase 3 Adult Onset and Duration Trial of CTx-1301 (dexmethylphenidate) for ADHD
April 04, 2023
From
Cingulate Inc.
Via
GlobeNewswire
Frequently Asked Questions
Is Cingulate Inc. - Warrants publicly traded?
Yes, Cingulate Inc. - Warrants is publicly traded.
What exchange does Cingulate Inc. - Warrants trade on?
Cingulate Inc. - Warrants trades on the Nasdaq Stock Market
What is the ticker symbol for Cingulate Inc. - Warrants?
The ticker symbol for Cingulate Inc. - Warrants is CINGW on the Nasdaq Stock Market
What is the current price of Cingulate Inc. - Warrants?
The current price of Cingulate Inc. - Warrants is 0.0369
When was Cingulate Inc. - Warrants last traded?
The last trade of Cingulate Inc. - Warrants was at 03/09/26 03:59 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
